Cellect Biotechnology rises on new patent allowance in China

Quoin Pharmaceuticals

02/04/2020 14:30

** U.S.-listed shares of biotechnology company  APOP.O  rise
37.6% to $1.90 premarket
    ** China National Intellectual Property Administration
grants APOP a patent for a device and a kit adapted to select
cells resistant to receptor-mediated apoptosis, which is the
process of programmed cell death  urn:newsml:reuters.com:*:nPn1VSWlSa
    ** Up to Wednesday's close, shares fell ~38% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))